{"transactions":[{"id":4632782,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-03T00:02:07.000Z","date":"2026-09-30","kind":"grant","planned":false,"acquired":true,"shares":206,"price":121.35,"value":24998.1,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 1,642 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":23225,"source":{"system":"sec-edgar","filing":"0001177917-26-000014","document":"wk-form4_1790971323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000117791726000014/wk-form4_1790971323.xml","form_type":"4"}},{"id":719800,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-02T20:07:20.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":255,"price":113.36,"value":28906.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 1,642 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":23019,"source":{"system":"sec-edgar","filing":"0001177917-26-000012","document":"wk-form4_1783022833.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000117791726000012/wk-form4_1783022833.xml","form_type":"4"}},{"id":743874,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2026-06-10T20:08:18.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":6111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":6111,"derivative":{"exercise_price":100.64,"expiration_date":"2036-06-07","underlying":"Common Stock","underlying_shares":6111},"source":{"system":"sec-edgar","filing":"0001177917-26-000011","document":"wk-form4_1781122095.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000117791726000011/wk-form4_1781122095.xml","form_type":"4"}},{"id":743873,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T20:08:18.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":1642,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including this grant, this includes an aggregate of 1,642 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":22764,"source":{"system":"sec-edgar","filing":"0001177917-26-000011","document":"wk-form4_1781122095.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000117791726000011/wk-form4_1781122095.xml","form_type":"4"}},{"id":757708,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-01T22:00:18.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":9311,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":9311,"derivative":{"underlying":"Common Stock","underlying_shares":9311},"source":{"system":"sec-edgar","filing":"0001177917-26-000009","document":"form4-06012026_060612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000117791726000009/form4-06012026_060612.xml","form_type":"4"}},{"id":757707,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2026-06-01T22:00:18.000Z","date":"2026-05-29","kind":"grant","planned":false,"acquired":true,"shares":16004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":16004,"derivative":{"exercise_price":21.66,"expiration_date":"2036-05-28","underlying":"Common Stock","underlying_shares":16004},"source":{"system":"sec-edgar","filing":"0001177917-26-000009","document":"form4-06012026_060612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000117791726000009/form4-06012026_060612.xml","form_type":"4"}},{"id":757706,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-01T22:00:18.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":false,"shares":8107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2026, the date on which an annual meeting of stockholders was held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2026, the date on which an annual meeting of stockholders was held."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8107},"source":{"system":"sec-edgar","filing":"0001177917-26-000009","document":"form4-06012026_060612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000117791726000009/form4-06012026_060612.xml","form_type":"4"}},{"id":757705,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-01T22:00:18.000Z","date":"2026-05-29","kind":"exercise","planned":false,"acquired":true,"shares":8107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":43148,"source":{"system":"sec-edgar","filing":"0001177917-26-000009","document":"form4-06012026_060612.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000117791726000009/form4-06012026_060612.xml","form_type":"4"}},{"id":821548,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-02T20:10:15.000Z","date":"2026-03-31","kind":"grant","planned":false,"acquired":true,"shares":269,"price":94.12,"value":25318.28,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":21122,"source":{"system":"sec-edgar","filing":"0001177917-26-000006","document":"wk-form4_1775160612.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000117791726000006/wk-form4_1775160612.xml","form_type":"4"}},{"id":953734,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-05T21:05:53.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":245,"price":98.77,"value":24198.65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":20853,"source":{"system":"sec-edgar","filing":"0001177917-26-000002","document":"wk-form4_1767647141.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000117791726000002/wk-form4_1767647141.xml","form_type":"4"}},{"id":1028465,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-02T20:08:53.000Z","date":"2025-09-30","kind":"grant","planned":false,"acquired":true,"shares":289,"price":84.81,"value":24510.09,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":20608,"source":{"system":"sec-edgar","filing":"0001177917-25-000004","document":"wk-form4_1759435730.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000117791725000004/wk-form4_1759435730.xml","form_type":"4"}},{"id":1096675,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-02T20:44:01.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":367,"price":68.1,"value":24992.7,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":20319,"source":{"system":"sec-edgar","filing":"0000879169-25-000069","document":"wk-form4_1751489017.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916925000069/wk-form4_1751489017.xml","form_type":"4"}},{"id":1114181,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2025-06-12T20:28:00.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":9216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":9216,"derivative":{"exercise_price":70.07,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":9216},"source":{"system":"sec-edgar","filing":"0001628280-25-030999","document":"wk-form4_1749760072.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000162828025030999/wk-form4_1749760072.xml","form_type":"4"}},{"id":1114180,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:28:00.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":2518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including this grant, this includes an aggregate of 2,518 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":19952,"source":{"system":"sec-edgar","filing":"0001628280-25-030999","document":"wk-form4_1749760072.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000162828025030999/wk-form4_1749760072.xml","form_type":"4"}},{"id":1128200,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-02T22:05:10.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":8107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":8107,"derivative":{"underlying":"Common Stock","underlying_shares":8107},"source":{"system":"sec-edgar","filing":"0001415889-25-015273","document":"form4-06022025_060607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925015273/form4-06022025_060607.xml","form_type":"4"}},{"id":1128199,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2025-06-02T22:05:10.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":13793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":13793,"derivative":{"exercise_price":22.29,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":13793},"source":{"system":"sec-edgar","filing":"0001415889-25-015273","document":"form4-06022025_060607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925015273/form4-06022025_060607.xml","form_type":"4"}},{"id":1128198,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-02T22:05:10.000Z","date":"2025-05-29","kind":"exercise","planned":false,"acquired":false,"shares":9387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2025, the date on which an annual meeting of stockholders was held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2025, the date on which an annual meeting of stockholders was held."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9387},"source":{"system":"sec-edgar","filing":"0001415889-25-015273","document":"form4-06022025_060607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925015273/form4-06022025_060607.xml","form_type":"4"}},{"id":1128197,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-02T22:05:10.000Z","date":"2025-05-29","kind":"exercise","planned":false,"acquired":true,"shares":9387,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":35041,"source":{"system":"sec-edgar","filing":"0001415889-25-015273","document":"form4-06022025_060607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925015273/form4-06022025_060607.xml","form_type":"4"}},{"id":1185021,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T20:05:38.000Z","date":"2025-03-31","kind":"grant","planned":true,"acquired":true,"shares":363,"price":60.55,"value":21979.65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 2,830 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":17434,"source":{"system":"sec-edgar","filing":"0001628280-25-016170","document":"wk-form4_1743624329.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000162828025016170/wk-form4_1743624329.xml","form_type":"4"}},{"id":1317106,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-03T18:06:01.000Z","date":"2024-12-31","kind":"grant","planned":true,"acquired":true,"shares":339,"price":69.07,"value":23414.73,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 2,830 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":17071,"source":{"system":"sec-edgar","filing":"0000879169-25-000003","document":"wk-form4_1735927555.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916925000003/wk-form4_1735927555.xml","form_type":"4"}},{"id":1395587,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-02T17:00:51.000Z","date":"2024-09-30","kind":"grant","planned":true,"acquired":true,"shares":378,"price":66.1,"value":24985.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 2,830 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":16732,"source":{"system":"sec-edgar","filing":"0000879169-24-000158","document":"wk-form4_1727888444.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000158/wk-form4_1727888444.xml","form_type":"4"}},{"id":1464334,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-02T17:22:13.000Z","date":"2024-06-28","kind":"grant","planned":false,"acquired":true,"shares":409,"price":60.62,"value":24793.58,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This includes an aggregate of 2,830 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":16354,"source":{"system":"sec-edgar","filing":"0000879169-24-000101","document":"wk-form4_1719940925.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000101/wk-form4_1719940925.xml","form_type":"4"}},{"id":1479843,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non Qualfied Stock Option (right to buy)","published_at":"2024-06-14T16:14:04.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":12517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vests in full on the first anniversary of the date of grant, or if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the option plan)."}],"balance_after":12517,"derivative":{"exercise_price":59.94,"expiration_date":"2034-06-11","underlying":"Common Stock","underlying_shares":12517},"source":{"system":"sec-edgar","filing":"0000879169-24-000092","document":"wk-form4_1718381636.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000092/wk-form4_1718381636.xml","form_type":"4"}},{"id":1479842,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-14T16:14:04.000Z","date":"2024-06-12","kind":"grant","planned":false,"acquired":true,"shares":2830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the RSU plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Including this grant, this includes an aggregate of 2,830 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":15945,"source":{"system":"sec-edgar","filing":"0000879169-24-000092","document":"wk-form4_1718381636.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000092/wk-form4_1718381636.xml","form_type":"4"}},{"id":1497020,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-31T22:00:13.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":9387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":9387,"derivative":{"underlying":"Common Stock","underlying_shares":9387},"source":{"system":"sec-edgar","filing":"0001415889-24-015086","document":"form4-05312024_060509.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924015086/form4-05312024_060509.xml","form_type":"4"}},{"id":1497019,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2024-05-31T22:00:13.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":15959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":15959,"derivative":{"exercise_price":14.62,"expiration_date":"2034-05-28","underlying":"Common Stock","underlying_shares":15959},"source":{"system":"sec-edgar","filing":"0001415889-24-015086","document":"form4-05312024_060509.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924015086/form4-05312024_060509.xml","form_type":"4"}},{"id":1497018,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-31T22:00:13.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":false,"shares":6652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2024, the date on which an annual meeting of stockholders was held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2024, the date on which an annual meeting of stockholders was held."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6652},"source":{"system":"sec-edgar","filing":"0001415889-24-015086","document":"form4-05312024_060509.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924015086/form4-05312024_060509.xml","form_type":"4"}},{"id":1497017,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-31T22:00:13.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":true,"shares":6652,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":25654,"source":{"system":"sec-edgar","filing":"0001415889-24-015086","document":"form4-05312024_060509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924015086/form4-05312024_060509.xml","form_type":"4"}},{"id":1555006,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-02T16:12:17.000Z","date":"2024-03-28","kind":"grant","planned":false,"acquired":true,"shares":413,"price":56.97,"value":23528.61,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,505 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":13115,"source":{"system":"sec-edgar","filing":"0000879169-24-000069","document":"wk-form4_1712074328.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000069/wk-form4_1712074328.xml","form_type":"4"}},{"id":1694819,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-03T17:07:42.000Z","date":"2023-12-29","kind":"grant","planned":false,"acquired":true,"shares":423,"price":62.79,"value":26560.17,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,505 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":12702,"source":{"system":"sec-edgar","filing":"0000879169-24-000003","document":"wk-form4_1704301653.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916924000003/wk-form4_1704301653.xml","form_type":"4"}},{"id":1769022,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-03T20:06:06.000Z","date":"2023-09-29","kind":"grant","planned":false,"acquired":true,"shares":389,"price":57.77,"value":22472.53,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,505 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":12279,"source":{"system":"sec-edgar","filing":"0000879169-23-000031","document":"wk-form4_1696363547.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000087916923000031/wk-form4_1696363547.xml","form_type":"4"}},{"id":1838135,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-05T20:01:01.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":390,"price":62.25,"value":24277.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,505 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":11890,"source":{"system":"sec-edgar","filing":"0001209191-23-040945","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123040945/doc4.xml","form_type":"4"}},{"id":1853314,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-06-16T20:00:39.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":11294,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the Amended and Restated 2010 Stock Incentive Plan)."}],"balance_after":11294,"derivative":{"exercise_price":61.44,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":11294},"source":{"system":"sec-edgar","filing":"0001209191-23-037799","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123037799/doc4.xml","form_type":"4"}},{"id":1853313,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:00:39.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":2505,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the Amended and Restated 2010 Stock Incentive Plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":11500,"source":{"system":"sec-edgar","filing":"0001209191-23-037799","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123037799/doc4.xml","form_type":"4"}},{"id":1867897,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-06T01:39:43.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":6652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":6652,"derivative":{"underlying":"Common Stock","underlying_shares":6652},"source":{"system":"sec-edgar","filing":"0001209191-23-034696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034696/doc4.xml","form_type":"4"}},{"id":1867896,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2023-06-06T01:39:43.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":11045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":11045,"derivative":{"exercise_price":23.9,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":11045},"source":{"system":"sec-edgar","filing":"0001209191-23-034696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034696/doc4.xml","form_type":"4"}},{"id":1867895,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-06T01:39:43.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":false,"shares":8552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8552},"source":{"system":"sec-edgar","filing":"0001209191-23-034696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034696/doc4.xml","form_type":"4"}},{"id":1867894,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-06T01:39:43.000Z","date":"2022-06-07","kind":"exercise","planned":false,"acquired":false,"shares":6391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6391},"source":{"system":"sec-edgar","filing":"0001209191-23-034696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034696/doc4.xml","form_type":"4"}},{"id":1867893,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-06T01:39:43.000Z","date":"2021-06-22","kind":"exercise","planned":false,"acquired":false,"shares":3059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3059},"source":{"system":"sec-edgar","filing":"0001209191-23-034696","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034696/doc4.xml","form_type":"4"}},{"id":1867892,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T01:39:43.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":true,"shares":8552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."}],"balance_after":19002,"source":{"system":"sec-edgar","filing":"0001209191-23-034696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034696/doc4.xml","form_type":"4"}},{"id":1867891,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T01:39:43.000Z","date":"2022-06-07","kind":"exercise","planned":false,"acquired":true,"shares":6391,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."}],"balance_after":10450,"source":{"system":"sec-edgar","filing":"0001209191-23-034696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034696/doc4.xml","form_type":"4"}},{"id":1867890,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T01:39:43.000Z","date":"2021-06-22","kind":"exercise","planned":false,"acquired":true,"shares":3059,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."}],"balance_after":4059,"source":{"system":"sec-edgar","filing":"0001209191-23-034696","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034696/doc4.xml","form_type":"4"}},{"id":1885192,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-05-19T16:17:34.000Z","date":"2023-05-19","kind":"exercise","planned":false,"acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested and were delivered to the Reporting Person on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested and were delivered to the Reporting Person on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service through such date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001169245-23-000030","document":"wf-form4_168452744179673.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924523000030/wf-form4_168452744179673.xml","form_type":"4"}},{"id":1885191,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T16:17:34.000Z","date":"2023-05-19","kind":"exercise","planned":false,"acquired":true,"shares":3750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock."}],"balance_after":9750,"source":{"system":"sec-edgar","filing":"0001169245-23-000030","document":"wf-form4_168452744179673.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924523000030/wf-form4_168452744179673.xml","form_type":"4"}},{"id":1930415,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-04T20:00:36.000Z","date":"2023-03-31","kind":"grant","planned":false,"acquired":true,"shares":326,"price":72.27,"value":23560.02,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,144 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":8995,"source":{"system":"sec-edgar","filing":"0001209191-23-022634","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123022634/doc4.xml","form_type":"4"}},{"id":2070429,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-04T21:02:02.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":302,"price":80.32,"value":24256.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,144 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":8669,"source":{"system":"sec-edgar","filing":"0001209191-23-000800","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919123000800/doc4.xml","form_type":"4"}},{"id":2134318,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-20T20:00:09.000Z","date":"2022-10-19","kind":"grant","acquired":true,"shares":165,"price":69.59,"value":11482.35,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly Board committee retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1. Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,144 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":8367,"source":{"system":"sec-edgar","filing":"0001209191-22-054184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122054184/doc4.xml","form_type":"4"}},{"id":2146048,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-04T20:03:51.000Z","date":"2022-09-30","kind":"grant","acquired":true,"shares":250,"price":66.64,"value":16660.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,144 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":8202,"source":{"system":"sec-edgar","filing":"0001209191-22-052166","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122052166/doc4.xml","form_type":"4"}},{"id":2218013,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-01T20:01:05.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":236,"price":75.97,"value":17928.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 2,144 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":7952,"source":{"system":"sec-edgar","filing":"0001209191-22-040184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122040184/doc4.xml","form_type":"4"}},{"id":2228900,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-06-17T20:00:46.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":9124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the Amended and Restated 2010 Stock Incentive Plan)."}],"balance_after":9124,"derivative":{"exercise_price":68.55,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":9124},"source":{"system":"sec-edgar","filing":"0001209191-22-037798","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122037798/doc4.xml","form_type":"4"}},{"id":2228899,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-17T20:00:46.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":2144,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the Amended and Restated 2010 Stock Incentive Plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":7716,"source":{"system":"sec-edgar","filing":"0001209191-22-037798","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122037798/doc4.xml","form_type":"4"}},{"id":2238136,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-10T00:27:07.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":8552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":8552,"derivative":{"underlying":"Common Stock","underlying_shares":8552},"source":{"system":"sec-edgar","filing":"0001209191-22-035666","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122035666/doc4.xml","form_type":"4"}},{"id":2238135,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2022-06-10T00:27:07.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":14368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":14368,"derivative":{"exercise_price":18.27,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":14368},"source":{"system":"sec-edgar","filing":"0001209191-22-035666","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122035666/doc4.xml","form_type":"4"}},{"id":2262220,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-05-20T16:44:39.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest and be delivered to the Reporting Person on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest and be delivered to the Reporting Person on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date."}],"balance_after":3750,"derivative":{"underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001169245-22-000061","document":"wf-form4_165307946306515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924522000061/wf-form4_165307946306515.xml","form_type":"4"}},{"id":2262219,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2022-05-20T16:44:39.000Z","date":"2022-05-19","kind":"grant","acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date."}],"balance_after":17500,"derivative":{"exercise_price":0.8419,"expiration_date":"2032-05-18","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001169245-22-000061","document":"wf-form4_165307946306515.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924522000061/wf-form4_165307946306515.xml","form_type":"4"}},{"id":2309828,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-04T20:00:49.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":240,"price":79.42,"value":19060.8,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,923 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":5572,"source":{"system":"sec-edgar","filing":"0001209191-22-022292","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122022292/doc4.xml","form_type":"4"}},{"id":2451965,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-01-04T21:17:33.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":253,"price":73.4,"value":18570.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,923 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":5332,"source":{"system":"sec-edgar","filing":"0001209191-22-000712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919122000712/doc4.xml","form_type":"4"}},{"id":2553179,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-10-04T20:36:09.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":237,"price":68.78,"value":16300.86,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,923 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":5079,"source":{"system":"sec-edgar","filing":"0001209191-21-058993","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121058993/doc4.xml","form_type":"4"}},{"id":2646196,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-02T11:32:14.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":208,"price":84.13,"value":17499.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,923 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":4842,"source":{"system":"sec-edgar","filing":"0001209191-21-044648","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121044648/doc4.xml","form_type":"4"}},{"id":2656312,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-24T20:41:32.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":6391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":6391,"derivative":{"underlying":"Common Stock","underlying_shares":6391},"source":{"system":"sec-edgar","filing":"0001209191-21-043041","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121043041/doc4.xml","form_type":"4"}},{"id":2656311,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2021-06-24T20:41:32.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":11637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":11637,"derivative":{"exercise_price":24.88,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":11637},"source":{"system":"sec-edgar","filing":"0001209191-21-043041","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121043041/doc4.xml","form_type":"4"}},{"id":2681306,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2021-06-04T18:08:59.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the 2022 annual meeting, subject to the reporting person's continuous service through each such date"}],"balance_after":14000,"derivative":{"exercise_price":3.53,"expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001169245-21-000063","document":"wf-form4_162284452303145.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000063/wf-form4_162284452303145.xml","form_type":"4"}},{"id":2692176,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-05-28T11:14:42.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":8010,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the Amended and Restated 2010 Stock Incentive Plan)."}],"balance_after":8010,"derivative":{"exercise_price":83.16,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":8010},"source":{"system":"sec-edgar","filing":"0001209191-21-036407","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121036407/doc4.xml","form_type":"4"}},{"id":2692175,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T11:14:42.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":1923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the Amended and Restated 2010 Stock Incentive Plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":4634,"source":{"system":"sec-edgar","filing":"0001209191-21-036407","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121036407/doc4.xml","form_type":"4"}},{"id":2765263,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-01T21:20:13.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":219,"price":81.27,"value":17798.13,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,282 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":2711,"source":{"system":"sec-edgar","filing":"0001209191-21-024163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121024163/doc4.xml","form_type":"4"}},{"id":2923334,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-05T22:00:40.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":207,"price":86.98,"value":18004.86,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,282 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":2492,"source":{"system":"sec-edgar","filing":"0001209191-21-001236","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919121001236/doc4.xml","form_type":"4"}},{"id":2956776,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-04T15:53:37.000Z","date":"2020-12-03","kind":"purchase","acquired":true,"shares":6000,"price":4.12,"value":24720.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.11 to $4.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) to this Form 4."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001169245-20-000109","document":"wf-form4_160711520255981.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000109/wf-form4_160711520255981.xml","form_type":"4"}},{"id":3019188,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-01T20:52:03.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":187,"price":89.74,"value":16781.38,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,282 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":2285,"source":{"system":"sec-edgar","filing":"0001209191-20-052642","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120052642/doc4.xml","form_type":"4"}},{"id":3057476,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-14T20:13:54.000Z","date":"2020-08-12","kind":"sale","acquired":false,"shares":10000,"price":83.32,"value":833200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":55163,"source":{"system":"sec-edgar","filing":"0001593968-20-001750","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177917/000159396820001750/primary_01.xml","form_type":"4"}},{"id":3084450,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-13T20:48:49.000Z","date":"2020-07-13","kind":"sale","acquired":false,"shares":10000,"price":93.4,"value":934000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":65163,"source":{"system":"sec-edgar","filing":"0001593968-20-001630","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177917/000159396820001630/primary_01.xml","form_type":"4"}},{"id":3095795,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-01T21:09:34.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":152,"price":103.97,"value":15803.44,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 1,282 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":2098,"source":{"system":"sec-edgar","filing":"0001209191-20-039796","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120039796/doc4.xml","form_type":"4"}},{"id":3100127,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-25T22:00:15.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":3059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":3059,"derivative":{"underlying":"Common Stock","underlying_shares":3059},"source":{"system":"sec-edgar","filing":"0001209191-20-038978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120038978/doc4.xml","form_type":"4"}},{"id":3100126,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2020-06-25T22:00:15.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":5579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":5579,"derivative":{"exercise_price":52.73,"expiration_date":"2030-06-22","underlying":"Common Stock","underlying_shares":5579},"source":{"system":"sec-edgar","filing":"0001209191-20-038978","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120038978/doc4.xml","form_type":"4"}},{"id":3110767,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-15T21:20:13.000Z","date":"2020-06-12","kind":"sale","acquired":false,"shares":30000,"price":91.79,"value":2753700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":75163,"source":{"system":"sec-edgar","filing":"0001593968-20-001466","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177917/000159396820001466/primary_01.xml","form_type":"4"}},{"id":3118988,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2020-06-08T20:34:11.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (i) June 4, 2021, and (ii) the 2021 annual meeting of the Issuer's stockholders."}],"balance_after":12500,"derivative":{"exercise_price":97.59,"expiration_date":"2030-06-04","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001593968-20-001420","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177917/000159396820001420/primary_01.xml","form_type":"4"}},{"id":3120775,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2020-06-05T18:55:11.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the 2021 annual meeting, subject to the reporting person's continuous service through each such date"}],"balance_after":16000,"derivative":{"exercise_price":4.86,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001169245-20-000061","document":"wf-form4_159139767242006.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000061/wf-form4_159139767242006.xml","form_type":"4"}},{"id":3132804,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-28T20:32:03.000Z","date":"2020-05-26","kind":"grant","acquired":true,"shares":10514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the Amended and Restated 2010 Stock Incentive Plan)."}],"balance_after":10514,"derivative":{"exercise_price":98.68,"expiration_date":"2030-05-25","underlying":"Common Stock","underlying_shares":10514},"source":{"system":"sec-edgar","filing":"0001209191-20-032603","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120032603/doc4.xml","form_type":"4"}},{"id":3132803,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-28T20:32:03.000Z","date":"2020-05-26","kind":"grant","acquired":true,"shares":1282,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the Amended and Restated 2010 Stock Incentive Plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":1946,"source":{"system":"sec-edgar","filing":"0001209191-20-032603","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120032603/doc4.xml","form_type":"4"}},{"id":3187732,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-02T22:07:55.000Z","date":"2020-03-31","kind":"grant","acquired":true,"shares":202,"price":73.23,"value":14792.46,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Restricted shares issued to the Reporting Person under the Issuer's Amended and Restated 2010 Stock Incentive Plan in lieu of quarterly director retainer fees pursuant to an election by the Reporting Person intended to comply with Rule 10b5-1.  Restricted shares are fully vested."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes an aggregate of 462 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested."}],"balance_after":664,"source":{"system":"sec-edgar","filing":"0001209191-20-022768","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919120022768/doc4.xml","form_type":"4"}},{"id":3216104,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-12T00:00:26.000Z","date":"2020-03-09","kind":"grant","acquired":true,"shares":105163,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":105163,"source":{"system":"sec-edgar","filing":"0000899243-20-007992","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177917/000089924320007992/doc4.xml","form_type":"4"}},{"id":3335653,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option","published_at":"2019-12-19T21:52:00.000Z","date":"2019-12-17","kind":"grant","acquired":true,"shares":4360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon change of control (as defined in the Amended and Restated 2010 Stock Incentive Plan)."}],"balance_after":4360,"derivative":{"exercise_price":91.31,"expiration_date":"2029-12-16","underlying":"Common Stock","underlying_shares":4360},"source":{"system":"sec-edgar","filing":"0001209191-19-061321","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119061321/doc4.xml","form_type":"4"}},{"id":3335652,"issuer":{"id":3182,"kind":"organization","name":"INCYTE CORP","symbol":"INCY"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-19T21:52:00.000Z","date":"2019-12-17","kind":"grant","acquired":true,"shares":462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This award of restricted stock units (\"RSUs\") vests in full on the first anniversary of the date of grant or, if earlier, the date of the next regular annual meeting of the Company's stockholders or upon a change of control (as defined in the Amended and Restated 2010 Stock Incentive Plan). The RSUs may be settled only for shares of common stock on a one-for-one basis."}],"balance_after":462,"source":{"system":"sec-edgar","filing":"0001209191-19-061321","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/879169/000120919119061321/doc4.xml","form_type":"4"}},{"id":3474863,"issuer":{"id":92934,"kind":"organization","name":"Karuna Therapeutics, Inc.","symbol":"KRTX"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-01T23:19:33.000Z","date":"2019-06-27","kind":"grant","acquired":true,"shares":16250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest in full upon the earlier of (i) June 27, 2020, and (ii) the next annual meeting of the Issuer's stockholders."}],"balance_after":16250,"derivative":{"exercise_price":16,"expiration_date":"2029-06-27","underlying":"Common Stock","underlying_shares":16250},"source":{"system":"sec-edgar","filing":"0000899243-19-018727","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177917/000089924319018727/doc4.xml","form_type":"4"}},{"id":3476273,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-28T21:10:55.000Z","date":"2019-06-26","kind":"grant","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable at the end of each 3-month period following the date of grant."}],"balance_after":22500,"derivative":{"exercise_price":25.24,"expiration_date":"2029-06-26","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-19-039523","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119039523/doc4.xml","form_type":"4"}},{"id":3489781,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T20:05:25.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in full on the one-year anniversary of the grant date."}],"balance_after":25000,"derivative":{"exercise_price":1.96,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001358403-19-000096","document":"wf-form4_156054271037497.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177917/000135840319000096/wf-form4_156054271037497.xml","form_type":"4"}},{"id":3530105,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2019-05-13T16:37:30.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":4583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the date of the 2020 annual meeting, subject to the reporting person's continuous service through each such date"}],"balance_after":4583,"derivative":{"exercise_price":13.23,"expiration_date":"2029-05-09","underlying":"Common Stock","underlying_shares":4583},"source":{"system":"sec-edgar","filing":"0001209191-19-029356","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000120919119029356/doc4.xml","form_type":"4"}},{"id":3729617,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-12-17T16:26:22.000Z","date":"2018-12-13","kind":"grant","acquired":true,"shares":68966,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in equal monthly installments over 36 months on the same day of the month as the Initial Vesting Date, subject to the reporting person's continued service through each such date."}],"balance_after":68966,"derivative":{"exercise_price":3.65,"expiration_date":"2028-12-13","underlying":"Common Stock","underlying_shares":68966},"source":{"system":"sec-edgar","filing":"0001209191-18-062943","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000120919118062943/doc4.xml","form_type":"4"}},{"id":3890915,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-18T20:30:42.000Z","date":"2018-06-14","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest and become exercisable in equal monthly installments until the Issuer's 2019 Annual Meeting of stockholders."}],"balance_after":10000,"derivative":{"exercise_price":9.8,"expiration_date":"2028-06-13","underlying":"Common Stock"},"source":{"system":"sec-edgar","filing":"0001358403-18-000060","document":"wf-form4_152935382297879.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177917/000135840318000060/wf-form4_152935382297879.xml","form_type":"4"}},{"id":3900453,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-08T21:06:56.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Annual committee grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable at the end of each 3-month period following the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":17.52,"expiration_date":"2028-06-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-18-000912","document":"form4-06082018_020641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918000912/form4-06082018_020641.xml","form_type":"4"}},{"id":3900452,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-08T21:06:56.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable at the end of each 3-month period following the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":17.52,"expiration_date":"2028-06-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-18-000912","document":"form4-06082018_020641.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918000912/form4-06082018_020641.xml","form_type":"4"}},{"id":4040749,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-02-22T21:04:13.000Z","date":"2018-02-20","kind":"grant","acquired":true,"shares":3166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests and becomes exercisable in equal installments on each of March 20, April 20, May 20, and June 14, 2018, and will vest in full upon a change in control."}],"balance_after":23166,"derivative":{"exercise_price":6.91,"expiration_date":"2028-02-19","underlying":"Common Stock","underlying_shares":3166},"source":{"system":"sec-edgar","filing":"0001358403-18-000027","document":"wf-form4_151933343834183.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1177917/000135840318000027/wf-form4_151933343834183.xml","form_type":"4"}},{"id":4040748,"issuer":{"id":107976,"kind":"organization","name":"BELLICUM PHARMACEUTICALS, INC","symbol":"BLCM"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-02-22T21:04:13.000Z","date":"2018-02-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and becomes exercisable in 36 equal monthly installments from the date of grant, and will vest in full upon a change in control."}],"balance_after":20000,"derivative":{"exercise_price":6.91,"expiration_date":"2028-02-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001358403-18-000027","document":"wf-form4_151933343834183.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1177917/000135840318000027/wf-form4_151933343834183.xml","form_type":"4"}},{"id":4254779,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-19T21:21:58.000Z","date":"2017-07-17","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable at the end of each 3-month period following the date of ACADIA's 2017 Annual Meeting of Stockholders, or June 13, 2017."}],"balance_after":15000,"derivative":{"exercise_price":28.85,"expiration_date":"2027-07-16","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-17-001228","document":"form4-07192017_020747.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001228/form4-07192017_020747.xml","form_type":"4"}},{"id":4282550,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":33395,"kind":"person","name":"HARRIGAN EDMUND","position":1,"cik":"0001177917","reported_name":"HARRIGAN EDMUND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-14T22:14:22.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable at the end of each 3-month period following the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":27.25,"expiration_date":"2027-06-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-17-000990","document":"form4-06142017_030611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000990/form4-06142017_030611.xml","form_type":"4"}}]}